The formation of the first complex is associated with the ability of CAV1 to inhibit β-catenin/Tcf-Lef-dependent transcription of genes including survivin, COX-2, and cyclinD1 and therefore function as a tumor suppressor. This evidence concerns the gene PTGS2 and neoplasm.